Purchases and Sales Made in Q2 2024 in Aura Biosciences, Inc. (AURA)
This table provides information about the institutional ownership of Aura Biosciences, Inc. (AURA) during Q2 2024. The information is specifically focused on institutions that hold shares of Aura Biosciences, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-4.02K- 4.62% |
$27.3K - $31.7K
|
82.8K
$510K
|
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-4.02K- 4.62% |
$27.3K - $31.7K
|
82.8K
$510K
|
|
|
Aug 13, 2024
Q2 2024
|
Entry Point Capital, LLC
New York, NY |
SELL
|
- |
-4.68K- 56.74% |
$31.9K - $36.9K
|
3.57K
$22K
|
|
|
Aug 14, 2024
Q2 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-8.28K- 32.61% |
$56.4K - $65.3K
|
17.1K
$105K
|
|
|
Aug 13, 2024
Q2 2024
|
Exchange Traded Concepts, LLC
|
SELL
|
- |
-9.06K- 23.73% |
$61.7K - $71.5K
|
29.1K
$179K
|
|
|
Jul 19, 2024
Q2 2024
|
Values First Advisors, Inc.
|
SELL
|
- |
-9.17K- 33.59% |
$62.4K - $72.3K
|
18.1K
$112K
|
|
|
Aug 09, 2024
Q2 2024
|
Connor, Clark & Lunn Investment Management Ltd.
|
SELL
|
- |
-12.6K- 17.62% |
$86K - $99.7K
|
59.1K
$364K
|
|
|
Aug 12, 2024
Q2 2024
|
Platinum Investment Management LTD
Sydney Australia 2000, C3 |
SELL
|
- |
-17.8K- 9.87% |
$121K - $140K
|
162K
$1M
|
|
|
Jun 12, 2025
Q2 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-19.9K- 51.66% |
$136K - $157K
|
18.7K
$115K
|
|
|
Aug 20, 2024
Q2 2024
|
Regency Capital Management Inc.\De
|
SELL
|
- |
-20.1K- 2.56% |
$137K - $158K
|
765K
$4.71M
|
|
|
Aug 14, 2024
Q2 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-21.9K- 3.68% |
$149K - $173K
|
574K
$3.53M
|
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-22.4K- 61.07% |
$152K - $177K
|
14.3K
$87.9K
|
|
|
Aug 14, 2024
Q2 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-25.9K- 27.18% |
$177K - $205K
|
69.5K
$428K
|
|
|
Aug 14, 2024
Q2 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-27.6K- 24.24% |
$188K - $218K
|
86.3K
$532K
|
|
|
Dec 26, 2024
Q2 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-27.7K- 51.81% |
$189K - $219K
|
25.8K
$159K
|
|
|
Aug 14, 2024
Q2 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-48.5K- 68.62% |
$330K - $383K
|
22.2K
$137K
|
|
|
Aug 14, 2024
Q2 2024
|
Nantahala Capital Management, LLC
New Canaan, CT |
SELL
|
- |
-51.8K- 3.92% |
$353K - $409K
|
1.27M
$7.82M
|
|
|
May 14, 2025
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-80.2K- 49.19% |
$546K - $633K
|
82.8K
$510K
|
|
|
Aug 13, 2024
Q2 2024
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
SELL
|
- |
-105K- 29.48% |
$717K - $831K
|
252K
$1.55M
|
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-1.34M- 36.38% |
$9.11M - $10.6M
|
2.34M
$14.4M
|